Collegium Pharmaceutical (NASDAQ:COLL) is a specialized company focusing on the development and commercialization of innovative therapies for pain management. The company aims to address the significant challenges in the pain management sector, such as the need for safer, abuse-deterrent formulations. Collegium Pharmaceutical is passionate about improving the lives of people suffering from pain and chronic conditions, guiding its project selection and research strategies towards achieving this goal. With a strong commitment to patient care, the company continuously seeks to advance its product portfolio through rigorous research and development, while also exploring strategic partnerships and acquisitions to expand its market reach. The objectives of Collegium Pharmaceutical revolve around delivering high-quality, effective treatments, and ensuring accessibility to those in need, thereby making a meaningful difference in the healthcare landscape.